Neuropharmacological mechanisms of ketamine;Wirkmechanismen von Ketamin

Anaesthesist

Volumn 46, Issue SUPPL. 1, 1997, Pages

  Kress, H G ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

acetylcholine receptor; anaesthetic action; anaesthetics, intravenous; dopamine; GABA receptor; interactions; ion channels; ketamine; neuron; neurotransmitter uptake; NMDA receptor; non NMDA receptor; noradrenaline; pharmacology; serotonin

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CALCIUM; CHOLINERGIC RECEPTOR; CYCLIC GMP; DOPAMINE; ION CHANNEL; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; NORADRENALIN; OPIATE RECEPTOR; PHENCYCLIDINE; POTASSIUM; SEROTONIN; SODIUM;

ANALGESIA; ANESTHESIA; BRAIN PROTECTION; DRUG MECHANISM; ENANTIOMER; HUMAN; NEUROTRANSMISSION; NONHUMAN; PHARMACODYNAMICS; REVIEW;

EID: 0030964150     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00002469     Document Type: Review

References (120)

1. Agulló L, García A (1992) Different receptors mediate stimulation of nitric oxide-dependent cyclic GMP formation in neurones and astrocytes in culture. Biochem Biophys Res Commun 182:1362-1368
2. Albin MS, Bunegin L, Massopust LC Jr, Jannetta PJ (1974) Ketamine-induced postanesthetic delirium attenuated by tetrahydroaminoacridine. Exp Neurol 44:126-129
3. Anis NA, Berry SC, Burton NR, Lodge D (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl D-aspartate. Br J Pharmacol 79:565-575
4. Arendt-Nielsen L, Petersen-Felix S, Fischer M, Bak P, Bjerring P, Zbinden AM (1995) The effect of N-methyl-D-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo-controlled experimental human study. Anesth Analg 81:63-68
5. Arhem P, Rydquist B (1986) The mechanism of action of ketamine on the myelinated nerve membrane. Eur J Pharmacol 126:245-251
6. Aronstam RS, Narayanan L, Wenger DA (1982) Ketamine inhibition of ligand binding to cholinergic receptors and ion channels. Eur J Pharmacol 78:367-370
7. Ashford MU, Boden P, Ramsey RL, Usherwood PNR (1989) Enhancement of desensitization of quisqualate-type glutamate receptor by the dissociative anaesthetic ketamine. J Exp Biol 141:73-86
8. -3H]aminobutyric acid uptake. Neuropharmacology 16:349-356
9. Balmer HGR, Wyte Sr (1977) Antagonism of ketamine by physostigmine. Br J Anaesth 49:510
10. Bansinath M, Warner W, Tang CK, Turndorf H, Puig MM (1992) On the mechanism of the interaction of ketamine and halothane in vitro. Gen Pharmacol 23:1183-1187
11. K) potassium currents in myocardium: implications for the mechanism of action. Anesth Analg 76:18-23
12. Beal MF (1992) Mechanisms of excitotoxicity in neurological diseases. FASEB J 6:3338-3344
13. Benoit E, Carratu MR, Dubois JM, Mitolo-Chieppa D (1986) Mechanism of action of ketamine in the current and voltage clamped myelinated nerve fibre of the frog. Br J Pharmacol 87:291-297
14. Björkman R, Hallman K, Hedner J, Hedner T, Henning M (1994) Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain 57:259-264
15. Bräu M, Sander F, Vogel W, Hempelmann G (1993) Untersuchung des lokalanästhetischen Effektes von Ketamin und seinen Stereoisomeren an einzelnen lonenkanälen des peripheren Nerven. Anaesthesist 42:871
16. Brockmeyer DM, Kendig JJ, (1995) Selective effects of ketamine on amino acid-mediated pathways in neonatal rat spinal cord. Br J Anaesth 74:79-84
17. Carlà V, Moroni F (1992) General anaesthetics inhibit the responses induced by glutamate receptor agonists in the mouse cortex. Neurosci Lett 146:21-24
18. Church J, Zeman S, Lodge D (1988) The neuroprotective action of ketamine and MK-801 after transient cerebral ischemia in rats. Anesthesiology 69:702-709
19. Crisp T, Perrotti JM, Smith DL, Stafinsky JL, Smith DJ (1991) The local monoaminergic dependency of spinal ketamine. Eur J Pharmacol 194:167-172
20. Coan EJ, Collingridge GL (1987) Effects of phencyclidine, SKF 10047 and related psychotomimetic agents on N-methyl-D-aspartate receptor mediated synaptic responses in rat hippocampal slices. Br J Pharmacol 91:547-556
21. Cohen ML, Chan SL, Way WL, Trevor AJ (1973) Distribution in the brain and metabolism of ketamine in the rat after intravenous administration. Anesthesiology 39:370-376
22. Davies SN, Lodge D (1987) Evidence for involvement of N-methylaspartate receptors in "wind-up" of class 2 neurones in the dorsal horn of the rat. Brain Res 424:402-406
23. Davies SN, Alford ST, Coan EJ, Lester RA, Collingridge GL (1988) Ketamine blocks a NMDA receptor-mediated component of synaptic transmission in rat hippocampus in a voltage-dependent manner. Neurosci Lett 92:213-217
24. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH (1993) Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 13:2651-2661
25. Domino EF, Chodoff P, Corssen G (1965) Pharmacologic effects of Cl-581, a new dissociative anesthetic in man. Clin Pharmacol Ther 6:279-291
26. Drummond JC, Brebner J, Galloon S, Young PS (1979) A randomized evaluation of the reversal of ketamine by physostigmine. Can Anaesth Soc J 26:288-295
27. Dubner R, Ruda MA (1992) Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci 15:96-103
28. Durieux ME (1995) Inhibition by ketamine of muscarinic acetylcholine receptor function. Anesth Analg 81:57-62
29. Endou M, Hattori Y, Nakaya H, Gotoh Y, Kanno M (1992) Electrophysiologic mechanisms responsible for inotropic responses to ketamine in guinea pig and rat myocardium. Anesthesiology 76:409-418
30. Feuerstein TJ (1994) Ketamin hemmt die N-Methyl-D-Aspartat (NMDA)-Rezeptor vermittelte Azetykholinfreisetzung aus N. caudatus-Schnitten des Kaninchens. Anaesthesist [Suppl 2] 43:S48-S51
31. Finck AD, Ngai SH (1982) Opiate receptor mediation of ketamine analgesia. Anesthesiology 56:291-297
32. Foster AC, Fagg GE (1987) Taking apart NMDA receptors. Nature 329:395-396
33. Frenkel C, Urban BW (1992) Molecular actions of racemic ketamine on human CNS sodium channels. Br J Anaesth 69:292-297
34. Gage PW, Robertson B (1985) Prolongation of inhibitory postsynaptic currents by pentobarbitone, halothane and ketamine in CA1 pyramidal cells of rat hippocampus. Br J Pharmacol 85:675-681
35. Gallagher JP, Dun N, Higashi N, Nishi S (1976) Actions of ketamine on sympathetic transmission in frog sympathetic ganglia. Neuropharmacology 15:139-143
36. Garthwaite J (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14:60-67
37. Garthwaite J, Charles SL, Chess-Williams R (1988) Endothelium-derived relaxing factor release an activation of NMDA receptors suggests role as intra cellular messenger in the brain. Nature 336:385-388
38. Galley HF, Nelson LR, Webster NR (1995) Anaesthetic agents decrease the activity of nitric oxide synthase from human polymorphonuclear leucocytes. Br J Anaesth 75:326-329
39. Gebhardt B (1994) Pharmakologie und Klinik der periduralen und intrathekalen Anwendung von Ketamin. Anaesthesist [Suppl 2] 43:S34-S40
40. Gonzales JM, Loeb AL, Reichard PS, Irvine S (1995) Ketamine inhibits glutamate-, N-methyl-D-aspartate- and quisqualate-stimulated cGMP production in cultured cerebral neurons. Anesthesiology 82:205-213
41. Gordh T, Karlsten R, Kristensen J (1995) Intervention with spinal NMDA, adenosine and NO systems for pain modulation. Ann Med 27:229-234
42. Harrison NL, Simmonds MA (1985) Quantitative studies on some antagonists of N-methyl D aspartate in slices of rat cerebral cortex. Br J Pharmacol 84:381-391
43. Hedner T, Quian Ling G, Hedner J, Samuelsson H (1991) Involvement of nitric oxide (NO) in nociceptive processing in the rat. (Abstract) Scandinavian Association for the Study of Pain, 15th Annual Meeting
44. Hoffman WE, Pelligrino D, Werner C, Kochs E, Albrecht RF, Schulte am Esch J (1992) Ketamine decreases plasma catecholamines and improves outcome from incomplete cerebral ischemia in rats. Anesthesiology 76:755-762
45. Hustveit O, Maurset A, Øye I (1995) Interaction of the chiral forms of ketamine with opioid, phencyclidine, and muscarinic receptors. Pharmacol Toxicol 77:355-359
46. Hustvei tO, Setekleiv J, Øye I (1992) Naloxone counteracts the fast development of tolerance to morphine in guinea-pig ileum. Pharmacol Toxicol 71:224-228
47. Ichinose F, Huang PL, Zapol WM (1995) Effects of targeted neuronal nitric oxide synthase gene disruption and nitroG-L-arginine methylester on the threshold for isoflurane anesthesia. Anesthesiology 83:101-108
48. Ikemoto Y (1986) Ketamine depression of excitatory and inhibitory cholinergic responses in Aplysia neurons. Eur J Pharmacol 132:97-100
49. Irifune M, Shimizu T, Nomoto M, Fukuda T (1992) Ketamine-induced anesthesia involves the N-methyl-D-aspartate receptor-channel complex in mice. Brain Res 569:1-9
50. Iversen LL (1963) The uptake of noradrenaline by the isolated perfused rat heart. Br J Pharmacol 21:523-537
51. Iversen LL (1965) The uptake of catecholamines at high perfusion concentrations in the rat isolated heart: a novel catecholamine uptake process. Br J Pharmacol 25:18-23
52. Jensen TS, Yaksh TL (1992) The antinociceptive activity of excitatory amino acids in the rat brainstem: An anatomical and pharmacological analysis. Brain Res 569:255-267
53. Johnson KM (1978) Neurochemical pharmacology of phencyclidine. NIDA Res Monogr 21:44-52
54. Johnson KM, Snell LD (1986) Involvement of dopaminergic, cholinergic and glutamatergic mechanisms in the actions of phencyclidine-like drugs. NIDA Res Monogr 64:52-66
55. Kandel ER, Schwartz JH, Jessel TM (1991) Principles of neural science, 3rd edn. Elsevier, New York Amsterdam
56. Kiedrowski L, Costa E, Wroblewski JT (1992) Glutamate receptor agonists stimulate nitric oxide synthase in primary cultures of cerebellar granule cells. J Neurochem 58:335-341
57. Klepstadt P, Maurset A, Ratti Moberg E, Øye I (1990) Evidence of a role for NMDA receptors in pain perception. Eur J Pharmacol 187:513-518
58. Kress HG (1994) NMDA- und Opiatrezeptor-unabhängige Wirkungen von Ketamin. Anaesthesist [Suppl 2] 43:S15-S24
59. 1) nicht an der Desipramin-Bindungsstelle. Anaesthesist 39:371-374
60. 2+ in neurones and non-muscular cells. Br J Anaesth 71:47-58
61. Kress HG, Rettig G, Seemann D (1992) Muscarinic receptor-mediated transmitter release is a potential target of ketamine enantiomers in chicken brain. Anesthesiology 77:A739
62. A receptors expressed by Xenopus oocytes: lack of involvement of intracellular calcium. J Pharmacol Exp Ther 263:569-578
63. Liske S, Li A, Morris ME (1990) Effects of ketamine on GABA-evoked excitability of peripheral nerve. Exp Brain Res 79:187-191
64. Löscher W, Fredow G, Ganter M (1991) Comparison of pharmacodynamic effects of the non-competitive NMDA receptor antagonists MK-801 and ketamine in pigs. Eur J Pharmacol 192:377-382
65. Lodge D, Anis NA (1984) Effects of ketamine and three other anaesthetics on spinal reflexes and inhibitions in the cat. Br J Anaesth 56:1143-1150
66. Lodge D, Johnson KM (1990) Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sci 11:81-86
67. Lodge D, Anis NA, Burton NR (1982) Effects of optical isomers of ketamine on excitation of cat and rat spinal neurons by amino acids and acetylcholine. Neurosci Lett 29:281-286
68. Loo PS, Braunwalder AF, Lehmann J, Williams M, Sills MA (1987) Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex. Mol Pharmacol 32:820-830
69. Lundy PM, Lockwood PA, Thompson G, Frew R (1986) Differential effects of ketamine isomers and neuronal and extraneuronal catecholamine uptake mechanisms. Anesthesiology 64:359-363
70. MacDonald AG, Ramsey RL, Shelton CJ, Usherwood PNR (1992) Single channel analysis of ketamine interaction with a quisqualate receptor. Eur J Pharmacol 210:223-229
71. MacDonald JF, Nowak LM (1990) Mechanisms of blockade of excitatory amino acid receptor channels. Trends Pharmacol Sci 11:167-170
72. MacDonald JF, Miljkovic Z, Pennefather P (1987) Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine. J Neurophysiol 58:251-266
73. Maleque MA, Warnick JE, Albuquerque EX (1981) The mechanism and site of action of ketamine on skeletal muscle. J Pharmacol Exp Ther 219:638-645
74. 3 receptors - a patch clamp-study. Neuropeptides 19:25-30
75. Mantz J, Desmonts JM (1991) La ketamine stimule la libération de dopamine dans le striatum: une étude in vitro chez le rat. Ann Fr Anesth Réanim [Suppl] 9:R71
76. Mantz J, Godbout R, Tassin JP, Glowinski J, Thierry AM (1990) Inhibition of spontaneous and evoked unit activity in the rat medial prefrontal cortex by mesencephalic raphe nuclei. Brain Res 525:22-30
77. Marin P, Quignard JF, Lafon-Cazal M, Bockaert J (1993) Non-classical glutamate receptors, blocked by both NMDA and non-NMDA antagonists, stimulate nitric oxide production in neurones. Neuropharmacology 32:29-36
78. Martin DC, Watkins CA, Adams RJ, Nason LA (1988) Anesthetic effects on 5-hydroxytryptamine uptake by rat brain synaptosomes. Brain Res 455:360-365
79. 2+-mediated currents in unmyelinated axons of rat olfactory cortex. Eur J Pharmacol 203:59-65
80. Mimura M, Namiki A, Kishi R, Ikeda T, Miyake H, Iwasaki H (1992) Central cholinergic action produces antagonism to ketamine anaesthesia. Acta Anaesthesiol Scand 36:460-462
81. Monaghan DT, Bridges RJ, Cotman CW (1989) The excitatory amino acid receptors: their classes, pharmacology and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29:365-402
82. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Sciences 256:1217-1221
83. 2+-block site of the NMDA receptor channel. Nature 358:673-675
84. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S (1991) Molecular cloning and characterization of the rat NMDA receptor. Nature 354:31-37
85. Muir WW, Hubbel JA (1988) Cardiopulmonary and anesthetic effects of ketamine and its enantiomers in dogs. Am J Vet Res 49:530-534
86. Nakanishi N, Axel R, Shneider NA (1992) Alternative splicing generates functionnally distinct N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA 89:8552-8556
87. Näsström J, Karlsson U, Post C (1992) Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice. Eur J Pharmacol 212:21-29
88. Øye I, Paulsen O, Maurset A (1992) Effects of ketamine on sensory perception: Evidence for a role of N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 260:1209-1213
89. Okamoto H, Hoka S, Kawasaki T, Okuyama T, Takahashi S (1994) L-arginine attenuates ketamine-induced increase in renal sympathetic nerve activity. Anesthesiology 81:137-146
90. Olney JW (1990) Excitatory amino acids and neuropsychiatrie disorders. Annu Rev Pharmacol Toxicol 30:47-71
91. Oshima E, Richards CD (1988) An in vitro investigation of the action of ketamine on excitatory synaptic transmission in the hippocampus of the guinea-pig. Eur J Pharmacol 148:25-33
92. Pekoe GM, Smith DJ (1982) The involvement of opiate and monoaminergic neuronal systems in the analgesic effects of ketamine. Pain 12:57-73
93. 3 receptor-mediated currents in rabbit nodose ganglion neurones. Br J Pharmacol 103:1623-1625
94. Ramabadran K, Bansinath M, Turndorf H, Puig MM (1990) A pharmacological analysis of the interaction of ketamine with kappa opiates. In: Domino EF (ed) Status of ketamine in anesthesiology, NPP Books, Ann Arbor, pp 211-227
95. Ren K, Hylden JLK, Williams GM et al. (1992) The effects of a non-competitive NMDA receptor antagonis MK-801 on behavioral hyperalgesia and dorsal horn neuronal activity in rat with unilateral inflammation. Pain 50:331-344
96. Rodriguez-Paz JM, Anantharam V, Treistman SN (1995) Block of the N-methyl-D-aspartate receptor by phencyclidine-like drugs is influenced by alternative splicing. Neurosci Lett 190:147-150
97. Rothman S (1988) Noncompetitive N-methyl-D-aspartate antagonist affect multiple ionic currents. J Pharmacol Exp Ther 246:137-142
98. Salt PJ, Barnes PK, Beswick FJ (1979) Inhibition of neuronal and extra neuronal uptake of noradrenaline by ketamine in the isolated perfused rat heart. Br J Anaesth 51:835-838
99. Scholfield CN (1980) Potentiation of inhibition by general anaesthetics in neurones of the olfactory cortex in vitro. Pflügers Arch 383:249-255
100. Seth S, Mukherjee D, Roy Choudhary AK, Sinha JN, Gurtu S (1990) Opioid and non-opioid central cardiovascular effects of ketamine. NaunynSchmiedeberg's Arch Pharmacol 342:535-538
101. Smith DJ, Azarro AJ, Turndorf H, Abbott SB (1975) The effect of ketamine HCl on the in vitro metabolism of norepinephrine in rat cerebral cortex tissue. Neuropharmacology 14:473-481
102. Smith DJ, Azarro AJ, Zaldivar SB, Palmer S, Lee HS (1981) Properties of the optical isomers and metabolites of ketamine on the high affinity transport and catabolism of monoamines. Neuropharmacology 20:391-396
103. Smith DJ, Bouchai RL, DeSanctis CA, Monroe PJ, Amedro JB, Perrotti JM, Crisp T (1982) Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro. Neuropharmacology 26:1253-1260
104. Smith DJ, Pekoe GM, Monroe PJ, Martin LL, Cabral MEY, Crisp T (1990) Ketamine analgesia in rats may be mediated by an interaction with opiate receptors. In: Domino EF (ed) Status of ketamine in anesthesiology. NPP Books, Ann Arbor, pp 199-209
105. Standaert DG, Testa CM, Young AB, Penney JB (1994) Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J Comp Neurol 343:1-16
106. Tobin JR, Martin LO, Breslow MJ, Traystman RJ (1994) Selective anesthetic inhibition of brain nitric oxide synthase. Anesthesiology 81:1264-1269
107. Toro-Matos A, Rendon-Platas AM, Avila-Valdez E, Villarreal-Guzman RA (1980) Physostigmine antagonizes ketamine. Anesth Analg 59:764-767
108. Vincent JP, Cavey D, Kamenka JM, Geneste P, Lazdunski M (1978) Interaction of phencyclidines with the muscarinic and opiate receptors in the central nervous system. Brain Res 152:176-182
109. Vincent JP, Kartalowski B, Geneste P, Kamenka JM, Lazdunski M (1979) Interaction of phencyclidine ("angel dust") with a specific receptor in rat brain membranes. Proc Natl Acad Sci USA 76:4678-4682
110. Wachtel R (1988) Ketamine decreases the open time of single-channel currents activated by acetylcholine. Anesthesiology 68:563-570
111. Wachtel R, Wegrzynowicz ES (1992) Kinetics of nicotinic acetylcholine ion channels in the presence of intravenous anaesthetics and induction agents. Br J Pharmacol 106:623-627
112. Wann KT (1993) Neuronal sodium and potassium channels: structure and function. Br J Anaesth 71:2-14
113. White PF, Ham J, Way WL, Trevor AJ (1980) Pharmacology of ketamine isomers in surgical patients. Anesthesiology 52:231-239
114. White PF, Schüttler J, Shafer A (1985) Comparative pharmacology of the ketamine isomers. Br J Anaesth 57:197-203
115. Wong BS, Martin CD (1993) Ketamine inhibition of cytoplasmic calcium signalling in rat pheochromocytoma (PC-12) cells. Life Sci 53:359-364
116. Wood JD, Hertz L (1980) Ketamine-induced changes in the GABA system of mouse brain. Neuropharmacology 19:805-808
117. Wood PL, Emmett MR, Rao TS, Cler J, Mick S, Iyengar S (1990) Inhibition of nitric oxide synthase blocks N-methyl-D-aspartate-, quisqualate-, kainate-, harmaline-, and pentylene-tetrazole-dependent increases in cerebellar cyclic GMP in vivo. J Neurochem 55:346-348
118. Woolf CJ (1989) Recent advances in the pathophysiology of acute pain. Br J Anaesth 63:139-146
119. Yamamura T, Harada K, Okamura A, Kemmotsu O (1990) Is the site of action of ketamine anesthesia the N-methyl-D-aspartate receptor? Anesthesiology 72:704-710
120. 3H] phencyclidine binding in rat central nervous system. Proc Natl Acad Sci USA 76:5372-5376